Department of Food Science and Nutrition, University of Minnesota-Twin Cities, St. Paul, Minnesota 55108-1038, USA.
Endocrinology. 2012 Mar;153(3):1183-93. doi: 10.1210/en.2011-1642. Epub 2012 Jan 10.
We have previously characterized lipocalin 2 (Lcn2) as a new adipokine having a critical role in energy and lipid metabolism in male mice. Previous studies by others have suggested that Lcn2 is a putative target gene of estrogens. In this study, we reported the effect of Lcn2 deficiency on estradiol biosynthesis and estrogen receptor signaling in female Lcn2-deficient (Lcn2-/-) mice. We found that Lcn2 expression in white adipose tissue is gender, depot, and age dependent. In female mice, Lcn2 is predominantly expressed in inguinal adipose tissue but at relatively very low levels in perigonadal depot and ovary. After 22 wk of high-fat diet (HFD) feeding or at old age, Lcn2-/- female mice had significantly reduced levels of serum 17β-estradiol and down-regulated expression of estrogen receptor α in multiple metabolic tissues. Consistently, the expression of estrogen-regulated genes involved in cholesterol homeostasis, such as liver X receptor β and low-density lipoprotein receptor was also down-regulated in the adipose tissue of Lcn2-/- mice. These changes were in line with the development of atherogenic dyslipidemia in response to HFD feeding; female Lcn2-/- mice had significantly elevated levels of total cholesterol and low-density lipoprotein cholesterol, whereas reduced high-density lipoprotein cholesterol levels compared with wild-type female mice. Interestingly, when compared with wild-type controls, HFD-fed female Lcn2-/- mice had significantly reduced expression levels of aromatase, a key enzyme regulating estradiol biosynthesis, in adipose tissue. Moreover, Lcn2 deficiency markedly blunted age-related increase in adipose aromatase expression but had no significant impact on age-related reduction in ovarian aromatase expression. Our findings suggest that Lcn2 has a tissue-specific role in adipose estradiol biosynthesis, which may link Lcn2 to obesity- and age-related estradiol production and metabolic complications in females.
我们之前已经将脂联素 2 (Lcn2) 鉴定为一种新的脂肪因子,它在雄性小鼠的能量和脂质代谢中具有关键作用。先前的研究表明,Lcn2 是雌激素的潜在靶基因。在这项研究中,我们报道了 Lcn2 缺乏对雌性 Lcn2 缺陷 (Lcn2-/-) 小鼠雌二醇生物合成和雌激素受体信号的影响。我们发现,白色脂肪组织中 Lcn2 的表达具有性别、脂肪组织和年龄依赖性。在雌性小鼠中,Lcn2 主要在腹股沟脂肪组织中表达,但在卵巢周围脂肪组织和卵巢中表达水平非常低。在高脂肪饮食 (HFD) 喂养 22 周或老年时,Lcn2-/-雌性小鼠的血清 17β-雌二醇水平显著降低,多种代谢组织中雌激素受体 α 的表达下调。一致地,涉及胆固醇稳态的雌激素调节基因的表达,如肝 X 受体 β 和低密度脂蛋白受体,也在 Lcn2-/-小鼠的脂肪组织中下调。这些变化与 HFD 喂养引起的动脉粥样硬化性血脂异常的发生一致;与野生型雌性小鼠相比,Lcn2-/-雌性小鼠的总胆固醇和低密度脂蛋白胆固醇水平显著升高,而高密度脂蛋白胆固醇水平降低。有趣的是,与野生型对照组相比,HFD 喂养的 Lcn2-/-雌性小鼠的脂肪组织中芳香酶的表达水平显著降低,芳香酶是调节雌二醇生物合成的关键酶。此外,Lcn2 缺乏显著减弱了与年龄相关的脂肪组织芳香酶表达增加,但对与年龄相关的卵巢芳香酶表达减少没有显著影响。我们的研究结果表明,Lcn2 在脂肪组织中具有特定的雌二醇生物合成作用,这可能将 Lcn2 与肥胖和年龄相关的雌激素产生以及女性的代谢并发症联系起来。